Darling Ingredients (DAR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Darling (DAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Jul 23, 2026

Why Darling (DAR) Could Beat Earnings Estimates Again

Darling (DAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • Jul 14, 2026

Darling Ingredients Inc. to Release Second Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) announced today that it will host a conference call on Thursday, July 30, 2026, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss second quarter 2026 financial results, which will be released earlier that day, and provide an update on company operations. A presentation with accompanying supplemental financial data will also be available at darlingii.com/investors. To access the call as a listener, please register for the.

Business Wire • Jul 9, 2026

Do Options Traders Know Something About Darling Ingredients Stock We Don't?

Investors need to pay close attention to DAR stock based on the movements in the options market lately.

Zacks Investment Research • Jul 2, 2026

4 Value Stocks to Buy Amid Costly AI Bets and Inflation

DAR, GPRE, TX and NEXA screen as high-earnings-yield value picks as inflation worries and AI spending fears sharpen stock selection.

Zacks Investment Research • Jun 26, 2026

4 Stocks to Buy as Online Grocery Sales Surge Amid Inflationary Woes

Online grocery sales jumped 19% in Q1 2026, putting TSN, CHEF, DAR and MAMA in focus amid rising grocery spending and high inflation.

Zacks Investment Research • Jun 25, 2026

Darling Ingredients' Health Brand Rousselot Receives U.S. Patent for Nextida® GC, the First Collagen Peptide Composition Supporting Blood Glucose Regulation

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) and its health brand Rousselot today announced that the U.S. Patent and Trademark Office (USPTO) has granted Patent No. US12636339 for Nextida GC, a first-of-its-kind collagen peptide ingredient developed to help support healthy after-meal blood sugar levels, naturally. The patent protects both the production process and the use of Nextida GC as a dietary supplement ingredient, offering a non-pharmaceutical option for managing.

Business Wire • Jun 3, 2026

Darling Ingredients: The Recovery Is Visible

Darling Ingredients (DAR) is rated Buy, supported by a visible earnings recovery, improved margins, and a compelling forward valuation versus peers. Q1 2026 delivered sharply higher EBITDA ($406.8M), gross margin expansion to 26.1%, and a return to profitability, signaling the roughest period is likely over. Core Feed and Food Ingredients segments drove margin and EBITDA gains without major volume growth, while DGD's Q1 result was boosted by a non-recurring inventory benefit.

Seeking Alpha • May 27, 2026

Darling Ingredients vs. Tyson Foods: Which Stock Stands Out?

DAR and TSN showcase contrasting food industry models as sustainability, protein demand and operational execution shape growth paths.

Zacks Investment Research • May 27, 2026

Is Darling Ingredients Entering a New Strategic Growth Phase?

DAR shifts focus toward cash flow, operational efficiency and balance-sheet flexibility as renewable fuels conditions improve.

Zacks Investment Research • May 25, 2026